Free Trial

Estée Lauder Companies (EL) Competitors

Estée Lauder Companies logo
$55.59 +0.36 (+0.65%)
As of 04/14/2025 03:58 PM Eastern

EL vs. PBH, IPAR, HLF, USNA, NUS, NATR, MED, VERU, CL, and HLN

Should you be buying Estée Lauder Companies stock or one of its competitors? The main competitors of Estée Lauder Companies include Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Colgate-Palmolive (CL), and Haleon (HLN).

Estée Lauder Companies vs.

Estée Lauder Companies (NYSE:EL) and Prestige Consumer Healthcare (NYSE:PBH) are both consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, community ranking, valuation, media sentiment, earnings and analyst recommendations.

Estée Lauder Companies pays an annual dividend of $1.40 per share and has a dividend yield of 2.5%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.3%. Estée Lauder Companies pays out -71.8% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Estée Lauder Companies is clearly the better dividend stock, given its higher yield and lower payout ratio.

Estée Lauder Companies currently has a consensus target price of $83.48, suggesting a potential upside of 50.16%. Prestige Consumer Healthcare has a consensus target price of $93.33, suggesting a potential upside of 13.64%. Given Estée Lauder Companies' higher possible upside, research analysts clearly believe Estée Lauder Companies is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estée Lauder Companies
0 Sell rating(s)
19 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.17
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Estée Lauder Companies has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500.

Prestige Consumer Healthcare has a net margin of 19.13% compared to Estée Lauder Companies' net margin of -4.61%. Estée Lauder Companies' return on equity of 16.82% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Estée Lauder Companies-4.61% 16.82% 4.00%
Prestige Consumer Healthcare 19.13%12.36%6.39%

Estée Lauder Companies received 701 more outperform votes than Prestige Consumer Healthcare when rated by MarketBeat users. However, 70.25% of users gave Prestige Consumer Healthcare an outperform vote while only 67.86% of users gave Estée Lauder Companies an outperform vote.

CompanyUnderperformOutperform
Estée Lauder CompaniesOutperform Votes
1197
67.86%
Underperform Votes
567
32.14%
Prestige Consumer HealthcareOutperform Votes
496
70.25%
Underperform Votes
210
29.75%

Estée Lauder Companies has higher revenue and earnings than Prestige Consumer Healthcare. Estée Lauder Companies is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estée Lauder Companies$15.18B1.31$390M-$1.95-28.51
Prestige Consumer Healthcare$1.12B3.64$209.34M$4.2719.23

55.2% of Estée Lauder Companies shares are held by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are held by institutional investors. 12.8% of Estée Lauder Companies shares are held by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Estée Lauder Companies had 21 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 31 mentions for Estée Lauder Companies and 10 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.34 beat Estée Lauder Companies' score of 0.83 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Estée Lauder Companies
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
6 Negative mention(s)
3 Very Negative mention(s)
Positive
Prestige Consumer Healthcare
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Estée Lauder Companies beats Prestige Consumer Healthcare on 11 of the 20 factors compared between the two stocks.

Remove Ads
Get Estée Lauder Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for EL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EL vs. The Competition

MetricEstée Lauder CompaniesToilet preparations IndustryStaples SectorNYSE Exchange
Market Cap$19.96B$10.64B$17.14B$18.51B
Dividend Yield2.63%3.37%3.04%4.25%
P/E Ratio-28.5114.2215.4031.06
Price / Sales1.314.703.3326.47
Price / Cash14.5417.9016.3917.54
Price / Book4.7911.956.334.29
Net Income$390M$332.81M$737.42M$1.02B
7 Day Performance11.82%9.09%4.26%6.72%
1 Month Performance-16.58%-9.55%-1.35%-6.79%
1 Year Performance-59.49%-16.64%-1.95%1.22%

Estée Lauder Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EL
Estée Lauder Companies
4.8059 of 5 stars
$55.59
+0.7%
$83.48
+50.2%
-59.9%$19.96B$15.18B-28.5163,000Analyst Forecast
Gap Up
PBH
Prestige Consumer Healthcare
4.1607 of 5 stars
$81.51
-1.6%
$93.33
+14.5%
+20.4%$4.04B$1.12B19.09540News Coverage
Positive News
IPAR
Inter Parfums
3.93 of 5 stars
$103.16
-0.9%
$162.80
+57.8%
-16.2%$3.32B$1.45B22.15530Short Interest ↑
Positive News
HLF
Herbalife
4.3371 of 5 stars
$7.69
-7.0%
$12.00
+56.0%
-18.4%$781.24M$4.99B3.1010,100Positive News
USNA
USANA Health Sciences
4.8289 of 5 stars
$24.64
-3.3%
$36.00
+46.1%
-44.1%$465.73M$854.50M8.701,900Upcoming Earnings
News Coverage
NUS
Nu Skin Enterprises
3.5462 of 5 stars
$6.11
-5.2%
$6.88
+12.6%
-49.8%$303.71M$1.73B-2.073,700Positive News
NATR
Nature's Sunshine Products
3.2672 of 5 stars
$11.20
-5.0%
$19.00
+69.7%
-36.3%$209.33M$454.36M12.87850Short Interest ↓
Gap Down
MED
Medifast
3.8137 of 5 stars
$13.03
-1.3%
$16.50
+26.7%
-59.0%$143.12M$602.46M72.69870News Coverage
Positive News
VERU
Veru
2.0713 of 5 stars
$0.58
+1.4%
$4.33
+649.7%
-64.1%$84.46M$16.89M-2.22230Positive News
CL
Colgate-Palmolive
4.2656 of 5 stars
$89.74
-2.1%
$102.06
+13.7%
+10.6%$72.76B$20.10B25.4933,800Positive News
HLN
Haleon
1.9119 of 5 stars
$9.30
-6.0%
$10.95
+17.8%
+26.5%$42.00B$11.23B27.3425,408Positive News
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NYSE:EL) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners